New Student Offer - Use Code HELLO

Register Now

Paxzen: A Generic COVID19 Tablet

Published on September 10, 2022
Current Context: Hyderabad-based drug company Zenara Pharma announced the launch of Paxzen tablets as a treatment option for patients with mild to moderate symptoms of Covid-19.
Paxzen: A Generic COVID19 Tablet
  • It is a generic version of Pfizer’s COVID-19 oral drug Paxlovid.
  • Pfizer’s Paxlovid got approval from the US Food and Drug Administration (FDA), in 2021.
  • The generic version, Paxgen, will contain a combination of two tablets, namely, Nirmatrelvir and Ritonavir.
  • The combination of these tablets will assist patients with mild to moderate symptoms of COVID-19.
  • A box of Paxzen will contain 20 tablets of Nirmatrelvir 150mg and 10 tablets of Ritonavir 100mg and the Maximum Retail Price (MRP) will be Rs. 5200 per box.
  • Zenara Pharma is a fully-owned subsidiary of Hyderabad-based Biophore India Pharmaceuticals and was incorporated in 2004. The Co-founder and Managing Director of Zenara Pharma are Jagadeesh Babu Rangisetty.

Question:

Q.1 The oral tablet for COVID19, Paxgen, will be manufactured by?
a. Serum Institute of India
b. Bharat Biotech
c. Zenara Pharma
d. Moderna
ebook store

About us

ramandeep singh

Ramandeep Singh, your guide to banking and insurance exams. With 14 years of experience and 5000+ selections, Ramandeep understands the path to success, having transitioned himself from Dena Bank and SBI. He's passionate about helping you achieve your banking and insurance dreams.

  • Follow me:
Close Menu
Close Menu